Company intelligence / Profile preview

APrevent Biotech

Vienna, Vienna, Austriaapreventmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

APrevent’s VOIS Implant is a CE-marked adjustable laryngeal implant for treating glottic insufficiency and unilateral vocal fold paralysis. Clinical studies have demonstrated safety and effectiveness in improving voice quality. The AiSpeak platform uses machine learning to improve communication for patients with motor speech disorders.

Therapeutic areas: OtherNeurology
Modalities: DeviceSoftware-as-a-Service (SaaS)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on APrevent Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on APrevent Biotech.

Explore the full profile